Pregabalin Capsule
Product Images NDC 13668-359

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 13668-359). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg (100mg)

Description: This text provides important information about Pregabalin capsules, including their dosage (100 mg) and storage requirements. It advises storing the capsules at 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F). The manufacturer is Torrent Pharmaceuticals Ltd from India, and they are dispensed by Torrent Pharmia Inc. It also instructs pharmacists to dispense the accompanying Medication Guide to each patient.*

FDA Label Image

150mg (150mg)

Each capsule contains 150 mg of Pregabalin USP. Store between 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F). Keep out of reach of children. Dispense in a tight container. Refer to the prescribing information for the usual dosage. Manufactured by Torrent Pharmaceuticals LTD, India, for Torrent Pharma Inc., Basking Ridge, NJ. NDC: 13668-362-30. *

FDA Label Image

200mg (200mg)

Each capsule contains 200 mg of Pregabalin USP with 30 capsules per pack. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication should be kept out of the reach of children and dispensed in a tight container with a child-resistant closure. The usual dosage should be determined based on the accompanying prescribing information. The pharmaceutical product is manufactured by TORF Pharmaceuticals LTD. The pharmacist is advised to dispense this medication with the accompanying Medication Guide to each patient.*

FDA Label Image

225mg (225mg)

Each capsule contains 225 mg of Pregabalin USP. This medication is stored at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The usual dosage information is provided in the prescribing information, and pharmacists are advised to dispense the accompanying Medication Guide to each patient. This product is manufactured by TORRENT PHARMACEUTICALS LTD. in India and distributed by TORRENT PHARMA INC. in Basking Ridge, NJ.*

FDA Label Image

25mg (25mg)

This text provides information about a medication called Pregabalin USP, with each capsule containing 25 mg. It includes instructions for proper storage, dosage, and dispensing, as well as manufacturer details from Torrent Pharmaceuticals Ltd. and TORRENT PHARMA INC. The text also emphasizes keeping the medication out of reach of children and dispensing it in a tight, child-resistant container. For more details on usage and prescribing instructions, one should refer to the accompanying prescribing information.*

FDA Label Image

300mg (300mg)

Each capsule of Pregabalin USP contains 300 mg of the active ingredient. It is recommended to store the medication at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). This drug should be kept out of the reach of children and dispensed in a tightly sealed container with a child-resistant closure. The usual dosage should be determined based on the accompanying prescribing information. The manufacturer is Torrent Pharmaceuticals Ltd. in India, and the medication is distributed by Torrent Pharma Inc. Additionally, the pharmacist is advised to provide the accompanying Medication Guide to each patient.*

FDA Label Image

50mg (50mg)

Each Pregabalin capsule contains 50 mg of the active ingredient. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). It must be kept out of reach of children and dispensed in a tight container with a child-resistant closure. The usual dosage information can be found in the prescribing information accompanying the product. This medication is manufactured by Torrent Pharmaceuticals Ltd. in India and is intended for distribution by Torrent Pharma Inc. in New Jersey, USA. Pharmacists are advised to dispense the accompanying Medication Guide to each patient.*

FDA Label Image

75mg (75mg)

Each capsule contains 75 mg of Pregabalin USP. Store between 20°C to 35°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Keep this and all drugs out of the reach of children. Dispense in a tight container with a child-resistant closure. Usual dosage: consult the accompanying prescribing information. This medication comes in a 30 capsules pack with NDC 13668-360-30. Pharmacists must dispense the accompanying Medication Guide to each patient. This product is available by prescription only.*

FDA Label Image

Image (9b61995b 06b7 40e3 B8cb 0e649ffbb2e6 269 2)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 01)

This text provides a formula for estimating creatinine clearance (CLr) in patients. CLr is calculated as [140 - age (years)] x weight (kg) if the patient is male, and [140 - age (years)] x weight (kg) x 0.85 if the patient is female, all divided by 72 x serum creatinine (mg/dL).*

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 02)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 03)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 04)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 05)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 06)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 07)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 08)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 09)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 10)

This is a table displaying responder rates (%) for different dosages. The responder rates are listed as 40.6%, 29.1%, and 22.6% for three different doses. The last line mentions placebo and two different dosages (2.5 mg/kg/day and 10 mg/kg/day) with corresponding values of 93, 103, and 9. These numbers likely indicate the number of responders at each dosage.*

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 12)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 13)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 14)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 15)

FDA Label Image

Image (Figure 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.